Crossject Société Anonyme (EPA:ALCJ)
1.940
+0.052 (2.75%)
At close: Feb 20, 2026
Crossject Société Anonyme Market Cap
Crossject Société Anonyme has a market cap or net worth of €102.32 million as of February 20, 2026. Its market cap has increased by 24.21% in one year.
Market Cap
102.32M
Enterprise Value
116.26M
Revenue
4.07M
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.94
Market Cap Chart
Since February 20, 2014, Crossject Société Anonyme's market cap has increased from 59.40M to 102.32M, an increase of 72.25%. That is a compound annual growth rate of 4.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 102.32M | -11.42% |
| Dec 31, 2025 | 115.50M | 10.53% |
| Dec 31, 2024 | 104.50M | -44.71% |
| Dec 29, 2023 | 188.99M | 90.83% |
| Dec 30, 2022 | 99.04M | 26.25% |
| Dec 31, 2021 | 78.44M | 0.92% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 110.27B |
| Sanofi | 96.10B |
| Sartorius Stedim Biotech | 17.78B |
| Ipsen | 12.95B |
| Adocia | 137.15M |
| Innate Pharma | 131.78M |
| ABIONYX Pharma | 118.36M |
| AB Science | 97.60M |